Literature DB >> 3044331

Paget's disease of bone.

A J Yates.   

Abstract

Paget's disease is a common disorder of bone of presumed viral aetiology which, in a minority of patients, may cause severe symptoms. Both calcitonin and the diphosphonates have specific anti-pagetic effects. Newer diphosphonates, unlike etidronate, do not impair mineralization, and when they become available these will be the drugs of choice. Until that time, both calcitonin and etidronate continue to have a useful place in the management of this disorder.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3044331     DOI: 10.1016/s0950-351x(88)80015-6

Source DB:  PubMed          Journal:  Baillieres Clin Endocrinol Metab        ISSN: 0950-351X


  6 in total

Review 1.  Calcitonin and calcitonin receptors: bone and beyond.

Authors:  M Pondel
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

Review 2.  Advances in the management of Paget's disease of bone.

Authors:  D J Hosking
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

3.  Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype.

Authors:  N Kurihara; S V Reddy; C Menaa; D Anderson; G D Roodman
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

4.  Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.

Authors:  C Menaa; S V Reddy; N Kurihara; H Maeda; D Anderson; T Cundy; J Cornish; F R Singer; J M Bruder; G D Roodman
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 5.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

6.  A Polyostotic Paget's Disease Involving Lumbar Spine Presenting with Cauda Equina Syndrome: An Unusual Entity.

Authors:  Shailesh Hadgaonkar; Shaunak Patwardhan; Pramod Bhilare; Parag Sancheti; Ashok Shyam
Journal:  J Orthop Case Rep       Date:  2021-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.